Switching from semaglutide, there was about 18 kg of weight maintained and about 1 kg of weight regained during 52 weeks of treatment [with orforglipron]. In an interview with Healio, Rachel Batterham, OBE, MBBS, PhD, FRCP, senior vice president of medical innovation and external engagement for Eli Lilly, said the ability for adults with obesity to maintain weight loss with orforglipron after receiving an injectable drug increases options for long-term therapy
A study published in July 2024 was the first to report a link between semaglutide and NAION
Women in perimenopause and menopause are already vulnerable to muscle loss, central fat gain, and sleep disruption
(2016) 11:e0151736
Essential testing protocols for research-grade peptides include: Reversed-phase high-performance liquid chromatography establishing total peptide purity percentages
Comparative copper-peptide research GHK-Cu is one of several copper-binding peptides studied in research, with AHK (Ala-His-Lys-Cu), various histidine-containing copper-binding peptides, and longer copper-binding peptide motifs (including the N-terminal albumin copper-binding site sequence DAHK and related sequences) all appearing in the broader literature